Loading...
Docoh
Log in Free sign up

RenovoRx (RNXT)

News

From Benzinga Pro
Stocks That Hit 52-Week Lows On Wednesday
11 May 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Wednesday, 807 companies reached new 52-week lows.
Stocks That Hit 52-Week Lows On Monday
25 Apr 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Monday, 721 companies achieved new lows for the year.
Stocks That Hit 52-Week Lows On Friday
22 Apr 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Friday, 431 companies hit new 52-week lows.
Stocks That Hit 52-Week Lows On Wednesday
20 Apr 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Wednesday, 160 companies hit new 52-week lows.

Press releases

From Benzinga Pro
RenovoRx and TIGeR-PaC Leadership to Host RenovoTAMP™ Webinar on June 21, 2022
9 Jun 22
Press Releases
"Facing Today's Challenges in Pancreatic Cancer Treatment: Understanding RenovoRx's Trans-Arterial Micro-Perfusion Therapy Platform" RenovoRx, Inc. (NASDAQ:RNXT), a biopharmaceutical company and innovator in targeted
RenovoRx to Participate in the University of Cambridge's Academy of Therapeutic Sciences Gateway to Translation Seminar Series on June 8, 2022
2 Jun 22
Press Releases
Dr. Ramtin Agah to Present, "Localized Intra-arterial Drug Delivery for Treatment of Solid Tumors" RenovoRx, Inc. (NASDAQ:RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced
RenovoRx to Present Preclinical Research Data Demonstrating its Innovative Therapy Platform's Potential Utility for the Treatment of Bile Duct Cancer
19 May 22
Press Releases
Study to be Presented at the Global Embolization Oncology Symposium Technologies (GEST) 2022 RenovoRx, Inc. ("RenovoRx" or the "Company") (NASDAQ:RNXT), a biopharmaceutical company and innovator in targeted cancer
RenovoRx Reports First Quarter 2022 Financial Results
16 May 22
Press Releases
RenovoRx, Inc. ("RenovoRx" or the "Company") (NASDAQ:RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today is reporting its financial results for the quarter ended March 31, 2022. "As we
RenovoRx Sponsors Pancreatic Cancer Action Network's PurpleStride Event to End Pancreatic Cancer
19 Apr 22
Press Releases
RenovoRx Raises Funds and Awareness to Fight World's Toughest Cancer RenovoRx, Inc. ("RenovoRx" or the "Company") (NASDAQ:RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, announced today it
RenovoRx Reports Full Year 2021 Financial Results
30 Mar 22
Press Releases
RenovoRx, Inc. ("RenovoRx" or the "Company") (NASDAQ:RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today is reporting its financial results for the year ended December 31, 2021. "2021 was